Evidence map›Paper›PMID 32327470›Full record

ArticleeNeuro

Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release.

Rémi Opsomer, Sabrina Contino, Florian Perrin, Roberta Gualdani, Bernadette Tasiaux, Pierre Doyen, Maxime Vergouts, Céline Vrancx, Anna Doshina, Nathalie Pierrot and 4 more

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neuronal activity-dependent gene dysregulation inAmerican journal of physiology. Cell physiology · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Amyloid β-Oligomers Inhibit the Nuclear CaAntioxidants (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Rémi OpsomerCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Sabrina ContinoCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Florian PerrinCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Roberta GualdaniCEllular and MOlecular Division-Laboratory of Cell Physiology, Institute of Neuroscience, Université Catholique de Louvain, B-1200, Brussels, Belgium.
Bernadette TasiauxCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Pierre DoyenCEllular and MOlecular Division-Laboratory of Neuropharmacology, Institute of Neuroscience.ORCID 0000-0001-8445-1287
Maxime VergoutsCEllular and MOlecular Division-Laboratory of Neuropharmacology, Institute of Neuroscience.
Céline VrancxCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Anna DoshinaCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Nathalie PierrotCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Jean-Noël OctaveCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Philippe GaillyCEllular and MOlecular Division-Laboratory of Cell Physiology, Institute of Neuroscience, Université Catholique de Louvain, B-1200, Brussels, Belgium.ORCID 0000-0002-9259-3813
Serena StangaCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience.
Pascal Kienlen-CampardCEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience pascal.kienlen-campard@uclouvain.be.ORCID 0000-0003-1086-2942
de Duve Institute · BECellular Research (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amyloid precursor protein (APP) has been extensively studied as the precursor of the β-amyloid (Aβ) peptide, the major component of the senile plaques found in the brain of Alzheimer's disease (AD) patients. However, the function of APP per se in neuronal physiology remains to be fully elucidated. APP is expressed at high levels in the brain. It resembles a cell adhesion molecule or a membrane receptor, suggesting that its function relies on cell-cell interaction and/or activation of intracellular signaling pathways. In this respect, the APP intracellular domain (AICD) was reported to act as a transcriptional regulator. Here, we used a transcriptome-based approach to identify the genes transcriptionally regulated by APP in the rodent embryonic cortex and on maturation of primary cortical neurons. Surprisingly, the overall transcriptional changes were subtle, but a more detailed analysis pointed to genes clustered in neuronal-activity dependent pathways. In particular, we observed a decreased transcription of neuronal PAS domain protein 4 (NPAS4) in APP-/- neurons. NPAS4 is an inducible transcription factor (ITF) regulated by neuronal depolarization. The downregulation of NPAS4 co-occurs with an increased production of the inhibitory neurotransmitter GABA and a reduced expression of the GABA

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAmyloid beta-PeptidesAnimalsBasic Helix-Loop-Helix Proteinsgamma-Aminobutyric AcidHumansMiceSynaptic TransmissionTranscription FactorsAmyloid beta-PeptidesAmyloid beta-Protein PrecursorBasic Helix-Loop-Helix Proteinsgamma-Aminobutyric AcidNpas4 protein, mouseTranscription Factorsamyloid precursor proteinCRISPR-Cas9GABAneuronal differentiationNPAS4transcriptome

Identifiers

PMID32327470
PMCPMC7262005
OpenAlexW3019942080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.